gadolinium dtpa has been researched along with epirubicin in 5 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 5,453 | 1,838 | 1,570 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | epirubicin (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.75 | ||
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestreri, L; Morassut, S | 1 |
| Hlawatsch, A; Hoffmann, G; Kuner, RP; Teifke, A; Thelen, M; Zamboglou, N | 1 |
| Delorme, S; Fink, C; Junkermann, H; Klein, SK; Lüdemann, HP; Sinn, HP; Wasser, K; Zuna, I | 1 |
| Ah-See, ML; Burcombe, RJ; Collins, DJ; d'Arcy, JA; Harrison, M; Makris, A; Padhani, AR; Pittam, MR; Ravichandran, D; Richman, PI; Stirling, JJ; Taylor, NJ | 1 |
| Fu, HX; Ji, JS; Lu, CY; Song, JJ; Teng, GJ; Yang, HY | 1 |
1 review(s) available for gadolinium dtpa and epirubicin
| Article | Year |
|---|---|
[Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therapeutic; Contrast Media; Drug Hypersensitivity; Epirubicin; Female; Gadolinium DTPA; Humans; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Angiography; Mitomycin | 1999 |
4 other study(ies) available for gadolinium dtpa and epirubicin
| Article | Year |
|---|---|
[MR mammography of response-control in primary chemo-brachytherapy in BCT-inoperable breast cancer].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Brachytherapy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Preoperative Care; Time Factors | 2001 |
Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Contrast Media; Cyclophosphamide; Epirubicin; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Remission Induction | 2003 |
Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Prospective Studies | 2008 |
[Preparation and in vivo-in vitro evaluation of compound nanoparticles loaded with epirubicin hydrochloride and gadopentetate meglumine].
Topics: Animals; Cell Line, Tumor; Drug Carriers; Drug Compounding; Epirubicin; Gadolinium DTPA; Nanoparticles; Particle Size; Rabbits | 2012 |